Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 80201-80250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05643677
Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancer
PHASE2Not yet recruiting
47 participants
Started: Dec 31, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor0 locations
NCT06345846
Stability of Secondary Intraocular Lenses With no Capsular Support
NAEnrolling by invitation
82 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05594095
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
PHASE2Recruiting
620 participants
Started: Dec 30, 2022 · Completed: Dec 1, 2026
5 conditions16 sponsors1 location
NCT05457699
Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)
PHASE2Recruiting
80 participants
Started: Dec 30, 2022 · Completed: Jul 30, 2030
1 condition1 sponsor1 location
NCT05617872
Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound
NARecruiting
75 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05136027
TReAtment With CombinedExercise in Patients With Resistant Major Depression
NARecruiting
70 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05562024
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
PHASE1Recruiting
24 participants
Started: Dec 30, 2022 · Completed: Feb 18, 2039
1 condition3 sponsors2 locations
NCT06234696
Cognitive Behavioral Therapy by Humor Based Psychoeducation
NAActive, not recruiting
60 participants
Started: Dec 30, 2022 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT05648968
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
PHASE3Recruiting
90 participants
Started: Dec 30, 2022 · Completed: May 2, 2029
1 condition1 sponsor89 locations
NCT05673525
A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis
NANot yet recruiting
131 participants
Started: Dec 30, 2022 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05616468
BGT007 Cell Treatment of Nasopharyngeal Carcinoma
EARLY_PHASE1Recruiting
23 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05659186
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
PHASE2Recruiting
20 participants
Started: Dec 30, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05646576
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
NARecruiting
90 participants
Started: Dec 30, 2022 · Completed: Apr 1, 2027
5 conditions2 sponsors1 location
NCT05672524
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
PHASE2Recruiting
37 participants
Started: Dec 30, 2022 · Completed: Dec 30, 2025
5 conditions1 sponsor7 locations
NCT05961787
A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)
NARecruiting
134 participants
Started: Dec 30, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05765032
Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
220 participants
Started: Dec 30, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT03137966
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers
PHASE2Not yet recruiting
174 participants
Started: Dec 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor0 locations
NCT05633732
Developing Echocardiography Image Quality Management System Based on Deep Learning
N/ARecruiting
2,000 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05837806
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)
PHASE2Recruiting
27 participants
Started: Dec 30, 2022 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT05703048
The Effect of Esmolol Versus Dexmedetomidine on Postoperative Pain Control in Endoscopic Sinus Surgery: A Randomized Trial
NARecruiting
70 participants
Started: Dec 30, 2022 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT06332508
Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)
PHASE1Recruiting
36 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06154135
Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes
N/AEnrolling by invitation
165 participants
Started: Dec 30, 2022 · Completed: Jul 30, 2026
1 condition1 sponsor12 locations
NCT05406570
Personalized Tidal Volume in ARDS (VT4HEMOD)
NARecruiting
10 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06027892
Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
NARecruiting
562 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05643560
An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A.
N/AActive, not recruiting
33 participants
Started: Dec 29, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT05623722
Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury
NARecruiting
116 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT05622409
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
N/ARecruiting
250 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor8 locations
NCT05377307
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
N/ARecruiting
49 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2037
5 conditions1 sponsor5 locations
NCT05263765
Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery
N/AEnrolling by invitation
100 participants
Started: Dec 29, 2022 · Completed: Dec 29, 2024
1 condition1 sponsor1 location
NCT05853198
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
NARecruiting
165 participants
Started: Dec 29, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05024773
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
PHASE3Recruiting
112 participants
Started: Dec 29, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor47 locations
NCT05627362
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.
PHASE2Active, not recruiting
68 participants
Started: Dec 29, 2022 · Completed: Aug 28, 2026
1 condition1 sponsor62 locations
NCT06258408
A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors
PHASE1Recruiting
78 participants
Started: Dec 29, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor2 locations
NCT05673057
Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
PHASE1/PHASE2Recruiting
249 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2029
4 conditions1 sponsor9 locations
NCT05654532
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
PHASE1Active, not recruiting
100 participants
Started: Dec 29, 2022 · Completed: May 31, 2026
1 condition1 sponsor9 locations
NCT05687851
Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
PHASE2Recruiting
33 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors1 location
NCT06273449
A Smart Digital Workflow Towards High Precision and Through-Put Production for Removable Partial Dentures
NARecruiting
141 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05687266
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
PHASE3Active, not recruiting
1,350 participants
Started: Dec 29, 2022 · Completed: Nov 1, 2027
1 condition1 sponsor255 locations
NCT04552080
The Effect of Systemic Antibiotics on Post-surgical Complications and Patient-centered Outcomes in Patients Undergoing Implant Surgery With Guided Bone Regeneration and Simultaneous Sinus Floor Elevation
PHASE4Recruiting
30 participants
Started: Dec 29, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05595642
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
PHASE3Recruiting
1,290 participants
Started: Dec 29, 2022 · Completed: Mar 11, 2027
1 condition1 sponsor462 locations
NCT05587543
Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma
EARLY_PHASE1Recruiting
24 participants
Started: Dec 28, 2022 · Completed: Oct 31, 2030
1 condition1 sponsor1 location
NCT05634070
Pectus Excavatum Camouflage (IT)
NAActive, not recruiting
10 participants
Started: Dec 28, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT05349370
Lactate Kinetics in Septic Shock
NARecruiting
60 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2026
2 conditions4 sponsors1 location
NCT06175780
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
189 participants
Started: Dec 28, 2022 · Completed: Dec 28, 2025
2 conditions1 sponsor8 locations
NCT05645536
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
PHASE3Enrolling by invitation
250 participants
Started: Dec 28, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor43 locations
NCT06142175
Relmacabtagene Autoleucel in Patients With LBCL
N/ARecruiting
200 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05442515
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
PHASE1/PHASE2Recruiting
126 participants
Started: Dec 28, 2022 · Completed: Jul 1, 2029
11 conditions1 sponsor1 location
NCT05249114
Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
PHASE1Active, not recruiting
6 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05464186
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
NARecruiting
200 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05556603
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)
N/ARecruiting
7,062 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2029
1 condition2 sponsors3 locations